Navigation Links
NEIKER and INRA discover that BDA symptoms in grapevine leaves are a sign of esca

This press release is available in Spanish.

Scientists at the Basque Institute of Agricultural Research and Development, NEIKER-Tecnalia, and the National Institute of Agricultural Research in Bordeaux (INRA) have come to the conclusion that alleged symptoms of 'black dead arm' (BDA) on grapevine leaves are, in fact, those of esca disease in its initial phase. Esca and BDA are diseases that affect the trunk of vines and cause serious losses to the wine-making and grape-growing sectors every year.

The symptoms produced by esca and BDA in vine leaves are reminiscent of those of drought. In the case of esca, the tissue between the veins dries up and appears surrounded by a red pigmentation and then another yellow discoloration before reaching the green, fresh tissue (tiger stripe pattern). The leaves which to date were believed to be affected by ''black dead arm" (BDA) only showed the red pigmentation beside the green tissue. This difference led some researchers to believe that two different diseases were involved.

With the goal of studying these signs more deeply, NEIKER-Tecnalia and INRA researchers undertook a fortnightly monitoring of affected vines over a period of three years, at a number of vineyards in the Rioja Alavesa (Spain), Bordeaux (France), the Rhine area (Germany) and the Bekaa Valley (Lebanon). The experts observed that the leaves progressed from the so-called BDA symptoms to those of esca, and even that both symptoms could be detected at the same time in many of the plants studied.

If two different, independent diseases were involved, most of the vines would show external signs of either BDA or esca; but not of both succesively.

Thus, the specialists concluded, both the leaves showing red markings and yellow ones beside the green tissue, as well as the ones showing red markings only, were affected by esca. Moreover, NEIKER-Tecnalia researchers have undertaken glasshouse trials in which they have inoculated botryosphaeriaceous fungi which cause BDA - into vines and have never managed to reproduce the alleged foliar BDA symptoms.

Research published in Plant Disease

The results of the NEIKER-Tecnalia and INRA research were published last July in the prestigious scientific journal Plant Disease, which shows one of the highest impact factors in this discipline. The study was financed by the Aquitaine-Euskadi euro-regional platform, with the collaboration of grape growers in the Famers Union of Araba/lava (UAGA)

Widespread throughout Europe

The esca disease is widespread throughout Europe. In order to understand its importance, it can be stated that 70% of French vineyards showed symptoms of esca/BDA during the 2003-2008 period, according to nationwide survey data. The affected vineyards had between 1% and 3% diseased plants, a very similar percentage to the one found in Rioja Alavesa.

To control this disease, sodium arsenite has been traditionally used, a chemical banned since 2003 given its extreme toxicity. Although there exist several alternative treatments on the market, they are not as effective against the fungi as the mentioned sodium arsenite. NEIKER-Tecnalia is currently testing chemical and biological treatments intended to be used on pruning wounds, which are the entry point for this disease.

Esca is a complex disease involving a succession of several fungi and affecting grapevine and other woody plants. It is one of the so-called grapevine trunk diseases since the fungi causing them grow within the wood of the trunk and branches. As the wood decays, from the inside towards the outside, the vascular tissues become affected and the normal flow of sap is impaired, to such an extent of inducing partial drying of leaves or even total wilting of canes.


Contact: Aitziber Lasa Iglesias
Elhuyar Fundazioa

Related biology news :

1. Neiker-Tecnalia identifies antitumour proteins in the latex of the plant Euphorbia trigona
2. Discovery of reprogramming signature may help further stem cell-based regenerative medicine research
3. Chinese scientists discover MVK mutations associated with DSAP
4. King Richard III search in new phase after discovery has potential to rewrite history
5. Scientists discover how the brain ages
6. Newly discovered letters and translated German ode expand Texas link to infamous Bone Wars
7. National herpetology society honors UT Arlington professor for discoveries
8. New discovery related to gum disease
9. New potential targets discovered for treating squamous cell lung cancers
10. Study in mice discovers injection of heat-generating cells reduces belly fat
11. New Danish fungal species discovered
Post Your Comments:
(Date:6/2/2016)... YORK , June 2, 2016   The Weather ... is announcing Watson Ads, an industry-first capability in which consumers ... by being able to ask questions via voice or text ... Marketers have long sought ... the consumer, that can be personal, relevant and valuable; and ...
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing ...  3D medical LCD display is the latest premium product recently added to the range ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/12/2016)... 12, 2016 , a brand ... overview results from the Q1 wave of its quarterly ... was consumers, receptivity to a program where they would ... health insurance company. "We were surprised to ... Michael LaColla , CEO of Troubadour Research, "primarily ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016 Houston Methodist Willowbrook Hospital has ... Association to serve as their official health care ... Willowbrook will provide sponsorship support, athletic training services, ... coaches, volunteers, athletes and families. "We ... Association and to bring Houston Methodist quality services ...
(Date:6/23/2016)... FRANCISCO , June 23, 2016   EpiBiome ... has secured $1 million in debt financing from Silicon ... ramp up automation and to advance its drug development ... its new facility. "SVB has been an ... beyond the services a traditional bank would provide," said ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... the Pennsylvania Convention Center and will showcase its product’s latest features from June ... be presenting a scientific poster on Disrupting Clinical Trials in The Cloud during ...
Breaking Biology Technology: